Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Caredx Inc (NASDAQ: CDNA) closed at $12.86 in the last session, up 1.10% from day before closing price of $12.72. In other words, the price has increased by $1.10 from its previous closing price. On the day, 1.1 million shares were traded. CDNA stock price reached its highest trading level at $13.29 during the session, while it also had its lowest trading level at $12.705.
Ratios:
We take a closer look at CDNA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.10 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 35.54. For the most recent quarter (mrq), Quick Ratio is recorded 3.84 and its Current Ratio is at 4.11. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on January 15, 2025, Upgraded its rating to Equal Weight and sets its target price to $24 from $28 previously.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.
BTIG Research Upgraded its Neutral to Buy on August 19, 2024, while the target price for the stock was maintained at $40.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 07 ’25 when Maag Peter sold 10,000 shares for $18.58 per share. The transaction valued at 185,831 led to the insider holds 308,846 shares of the business.
Valantine Hannah sold 10,570 shares of CDNA for $202,566 on Jun 18 ’25. The Director now owns 38,994 shares after completing the transaction at $19.16 per share. On Jun 17 ’25, another insider, Maag Peter, who serves as the Director of the company, sold 10,000 shares for $19.24 each. As a result, the insider received 192,420 and left with 318,846 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 716051200 and an Enterprise Value of 515411872. As of this moment, Caredx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.16, and their Forward P/E ratio for the next fiscal year is 203.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.07 while its Price-to-Book (P/B) ratio in mrq is 1.88. Its current Enterprise Value per Revenue stands at 1.488 whereas that against EBITDA is -20.431.
Stock Price History:
The Beta on a monthly basis for CDNA is 2.21, which has changed by -0.45462257 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $10.96. The 50-Day Moving Average of the stock is -26.71%, while the 200-Day Moving Average is calculated to be -36.89%.
Shares Statistics:
According to the various share statistics, CDNA traded on average about 1.57M shares per day over the past 3-months and 3501460 shares per day over the past 10 days. A total of 55.46M shares are outstanding, with a floating share count of 51.93M. Insiders hold about 6.73% of the company’s shares, while institutions hold 100.94% stake in the company. Shares short for CDNA as of 1752537600 were 6399574 with a Short Ratio of 4.07, compared to 1749772800 on 6276371. Therefore, it implies a Short% of Shares Outstanding of 6399574 and a Short% of Float of 11.75.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
